{
    "clinical_study": {
        "@rank": "161469", 
        "arm_group": {
            "arm_group_label": "AccuCath Intravenous Catheter System", 
            "arm_group_type": "Experimental", 
            "description": "AccuCath Intravenous Catheter System will be used for IV therapy during inpatient stay.  Intervention includes vascular access, fluid infusion, and blood sample removal."
        }, 
        "brief_summary": {
            "textblock": "The study will test a hypothesis that the AccuCath\u2122 System will have a higher rate of\n      successful first attempt PIV placement, higher completion of therapy, fewer complications,\n      longer dwell times and higher user satisfaction compared to Conventional IV Catheters."
        }, 
        "brief_title": "AccuCath\u2122 Intravenous Catheter System Compared to Conventional Peripheral Intravenous Catheters", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Vascular Access Complication", 
        "detailed_description": {
            "textblock": "Phase One is designed as a one arm prospective study to compare patients using the AccuCath\u2122\n      Intravenous Catheter System to the results found in literature.  Phase Two is designed as a\n      two arm prospective randomized controlled study comparing the AccuCath\u2122 Intravenous Catheter\n      System to conventional PIV catheters.  This study site will be completing Phase One only."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female, age > or equal to 18 years or < or equal to 89 years old;\n\n          2. Capable and willing to give informed consent;\n\n          3. English speaking;\n\n          4. Acceptable candidate for an elective, non-emergent PIV as determined by ordering\n             physician;\n\n          5. Admitted to study inpatient unit.\n\n        Exclusion Criteria:\n\n          1. Male or female, < 18 years old or > 89 years old;\n\n          2. Requirement for emergent IV placement (patient's condition would be compromised if\n             there is a delay in IV placement);\n\n          3. Previous venous grafts or surgery at the target vessel access site;\n\n          4. Currently involved in other investigational clinical trials (unless permission is\n             granted by other study PI);\n\n          5. Females who are pregnant, planning to become pregnant within 3 months of the\n             procedure, or lactating."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "89 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01937195", 
            "org_study_id": "VPW-STP-00002"
        }, 
        "intervention": {
            "arm_group_label": "AccuCath Intravenous Catheter System", 
            "description": "AccuCath IV Catheter System will be used for IV therapy during inpatient stay.  Intervention includes vascular access, fluid infusion, and blood sample removal.  Results will be compared to published literature for conventional IV catheters.", 
            "intervention_name": "AccuCath Intravenous Catheter System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "IV Catheter comparison", 
            "AccuCath versus Conventional IV Catheters", 
            "IV Catheter Study", 
            "IV Catheter User Preference Comparison", 
            "First Attempt Success Rate for IV Catheters", 
            "AccuCath Device Performance", 
            "Complication Rates for IV Catheters", 
            "Average Dwell Time for IV Catheters", 
            "Patient Satisfaction with IV Catheters", 
            "Clinician Satisfaction with AccuCath Device Performance"
        ], 
        "lastchanged_date": "September 3, 2013", 
        "location": {
            "contact": {
                "email": "nanderson@evanhospital.com", 
                "last_name": "Norman R Anderson, RN", 
                "phone": "570-222-2000"
            }, 
            "facility": {
                "address": {
                    "city": "Lewisburg", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "17837"
                }, 
                "name": "Evangelical Community Hospital"
            }, 
            "investigator": {
                "last_name": "Norman R Anderson, RN", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Randomized, Controlled, Multicenter Comparison Between the AccuCath\u2122 Intravenous Catheter System With Retractable Coiled Tip Guidewire and Conventional Peripheral Intravenous Catheters", 
        "overall_contact": {
            "email": "nanderson@evanhospital.com", 
            "last_name": "Norman R Anderson, RN", 
            "phone": "5705222000"
        }, 
        "overall_official": {
            "affiliation": "Evangelical Community Hospital", 
            "last_name": "Norman R Anderson, RN", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint is to observe first attempt success rate in patients requiring PIV access by documenting the number of catheter attempts (each new catheter) required to complete successful PIV placement.", 
            "measure": "First attempt success rate with peripheral IV catheter placement", 
            "safety_issue": "No", 
            "time_frame": "Baseline/at catheter placement"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01937195"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Will measure the rate of observed (anticipated) complications of IV therapy - infection, occlusion, infiltration, extravasation, phlebitis, dislodgement, leaking/bleeding at site, patient complaints of pain without other identifiable cause, and other (up to 7 days).", 
                "measure": "Complications of peripheral IV therapy", 
                "safety_issue": "No", 
                "time_frame": "Study exit/at catheter removal expected to be no more than 7 days post placement"
            }, 
            {
                "description": "Completion of IV therapy will measure whether the catheter remained in place for the duration of required intravenous treatment during the inpatient stay (up to  7 days).", 
                "measure": "Completion of IV therapy", 
                "safety_issue": "No", 
                "time_frame": "Study exit/at catheter removal expected to be no more than 7 days post placement"
            }, 
            {
                "description": "Will measure total catheter dwell time to the nearest hour (total time in hours for functioning catheter)up to 7 days.", 
                "measure": "Catheter dwell time", 
                "safety_issue": "No", 
                "time_frame": "Study exit/at catheter removal expected to be no more than 7 days post placement"
            }, 
            {
                "description": "Will survey patients regarding satisfaction with catheter insertion and at catheter removal regarding overall performance during use of peripheral IV catheter.", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "Baseline at catheter insertion and study exit at catheter removal expected to be no more than 7 days post placement"
            }, 
            {
                "description": "Will measure the number and severity of adverse events associated with peripheral IV initiation and indwelling catheter time (anticipated to be similar in both groups) up to 7 days.", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, and up to catheter removal expected to be no more than 7 days post placement"
            }, 
            {
                "description": "Will measure clinician satisfaction via a survey based on overall catheter performance during experience and use.", 
                "measure": "Clinical Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "At completion of study - expected to be no more than 6 months from start"
            }
        ], 
        "source": "Vascular Pathways, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vascular Pathways, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}